Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia.
Authors: Madarang E; Department of Pharmacy, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Lykon J; Department of Pharmacy, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Zhao W; Sylvester Comprehensive Cancer Center, Miller School of Medicine at University of Miami, Miami, FL., Sekeres MA; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Bradley T; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Chandhok NS; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Taylor J; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Venugopal S; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Koru-Sengul T; Sylvester Comprehensive Cancer Center, Miller School of Medicine at University of Miami, Miami, FL., Iyer SG; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY., Gilbert JS; Department of Internal Medicine, University of Colorado, Anschutz Medical Campus, Aurora CO., Miller RM; Department of Oncology Pharmacy, Vanderbilt University Medical Center, Nashville, TN., Nanni J; Dipartimento di Scienze Mediche e Chirurgiche, Istituto di Ematologia 'Seràgnoli,' Università degli Studi di Bologna, Bologna, Italy., Zacheo I; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Mattei A; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Al Ali N; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL., Kishtagari A; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Marconi G; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Sallman DA; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL., Pollyea DA; Department of Internal Medicine, University of Colorado, Anschutz Medical Campus, Aurora CO., Savona MR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli,' Bologna, Italy., Komrokji R; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL., Watts J; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL.
Source: Blood neoplasia [Blood Neoplasia] 2024 May 09; Vol. 1 (2), pp. 100016. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-3280
DOI:10.1016/j.bneo.2024.100016